Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial.
NCT ID: NCT02594631
Last Updated: 2015-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2015-03-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones
NCT03243682
Ultra Mini Percutaneous Nephrolithotomy VS Stented Extracorporeal Shock Wave Lithotripsy for Stone Management
NCT05697341
Treatment of Upper Ureteric Stones
NCT02469766
(SWL) Versus (ODT) Versus Combined SWL And ODT For Radiolucent Stone
NCT03388060
Mini- Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy for High Density Renal Stones
NCT04346134
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ESWL Group
Patients in this arm will receive ESWL as treatment for acute calcular urinary retention
ESWL
Patients in this arm will receive ESWL for treatment of acute calcular urinary retention
Endoscopy group
Patients in this arm will receive endoscopic treatment for acute calcular urinary retention
Endoscopic treatment
Patients in this arm will receive endoscopic treatment of acute calcular urinary retention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ESWL
Patients in this arm will receive ESWL for treatment of acute calcular urinary retention
Endoscopic treatment
Patients in this arm will receive endoscopic treatment of acute calcular urinary retention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. with a stone size not more than 2 centimeters in greatest diameter.
3. No more than 2 stones.
Exclusion Criteria
2. Bladder replacement of any type.
3. Infravesical obstruction, due to marked benign prostatic hyperplasia, prostate cancer, stricture urethra or external urethral meatal stenosis.
18 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Ali
Resident in Urology, Urology and Nephrology Center, Mansoura University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed A Shokeir, Prof
Role: STUDY_CHAIR
Urology and Nephrology Cenetr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology an Nephrology Center
Al Mansurah, DK, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MALI1112015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.